Winston R. Brown, Jr. Joins Alexza Pharmaceuticals, Inc. As Vice President, Quality
Mr. Brown brings more than two decades of experience in global quality, regulatory compliance and development operations working with diverse biopharmaceuticals, medical devices and nutritionals in globally integrated companies.
Alexza to Report 2014 First Quarter Financial Results on Monday, May 5, 2014
Alexza Pharmaceuticals, Inc. will report results for its fiscal quarter ended March 31, 2014 on Monday, May 5, 2014, following the close of the U.S. financial markets.
Bay Area's Alexza Pharmaceuticals, Inc. Reels In $45 Million Private Placement
The Notes are secured by royalties and potential milestones from U.S. sales of ADASUVEA inhalation powder.
Alexza raises $45M
Alexza Pharmaceuticals closes $45M non-recourse notes in a private placement. Interest rate is 12.25%/year beginning June 15. Royalty payments are tiered based on net commercial sales.